Thomas Hartman, President and CEO of ISPE and the ISPE Foundation, is interviewed by
Thomas Hartman, President and CEO of ISPE and the ISPE Foundation, is interviewed by
The biotechnology industry continues to evolve, advancing the frontiers of science and engineering in the design, development, and manufacture of a wide variety of therapeutic modalities. Advances in cell and gene therapies continue to offer treatments for diseases that were previously uncurable, with seven approvals in 2023, including treatments for sickle-cell disease, hemophilia, type 1...
The International Society of Pharmaceutical Engineering’s (ISPE) Women in Pharma® group was established in 2017. Since its inception, it has grown to a community of more than 2,000 members who are actively engaged in educational, collaborative, and networking activities designed to bridge gender, cultural, organizational, and geographic boundaries, maximize the impact women have in...
All session times are listed in Eastern Time (ET). Find your personal viewing time on the World Clock.